ELEVEN INSIGHTS · MARKET MONITOR
Brazil credit insurance
Market monitor | Premiums, participation, claims and reinsurance
Data through August 2026 · Seven-insurer sampleExecutive summary
- ProductionBRL 1,128.9 million in direct premiums over the 12 months ended August 2026. January–August 2026 production increased 15.2% versus the same period of 2025.
- ParticipationCoface and Allianz Trade account for 45.2% of sample premiums. Avla rose from 2.6% to 7.9% since 2023: the largest gain, at 5.3 percentage points using rounded shares.
- ClaimsThe gross loss ratio reached 165% in the trailing 12 months, versus 125% in calendar 2025. These windows overlap and are not consecutive calendar years.
- ReinsuranceCumulatively from January 2023 through August 2026, the gross ratio was 112%, versus 29% on the study’s estimated net basis. These are not consolidated group results.
- ConcentrationFour insurers recorded BRL 601.1 million in claims in August 2026. The query does not identify a borrower or establish a common event.
- CoverageThe sample accounts for 40.1% of branch 0748 premiums and 100% of branch 0749 premiums in the trailing period. Participation figures use the sample, not the entire Brazilian market.
¹ Own estimate in the supplied study. A local-entity reinsurance-adjusted metric, not consolidated profitability. The 165% and 36% both cover the same trailing 12-month window.
Premiums and production mix
Sample production rose from BRL 650.4 million in January–August 2025 to BRL 749.2 million in the same period of 2026, an increase of 15.2%. Over the 12 months ended August 2026, domestic credit accounted for BRL 1,002.2 million, or 88.8% of production, and export credit for BRL 126.7 million, or 11.2%.
The trailing total combines September–December 2025 with January–August 2026. Its 9.6% difference from full-year 2025 compares distinct windows and is not used here as a year-over-year growth rate.
Premiums grew 15.2% in comparable periods
Direct premiums · domestic and export credit · seven insurers
Underlying data
| Period | BRL million |
|---|---|
| Jan–Aug 2025 | 650.4 |
| Jan–Aug 2026 | 749.2 |
Participation and insurer ranking
Coface reports BRL 256.1 million in trailing 12-month direct premiums, followed by Allianz Trade at BRL 254.1 million. Their shares within the sample are 22.7% and 22.5%. A difference of 0.2 percentage points supports describing leadership as shared.
Their combined share declined from 50.9% in 2023 to 45.2%. Avla’s share rose from 2.6% to 7.9%. This describes recorded production; it does not, by itself, establish changes in appetite, portfolio quality or capacity available for an individual transaction.
Participation within the sample: two leaders, a narrower gap
Direct premiums · domestic and export credit combined
Swipe to view the full chart.
| Insurer | 12M premiums | Share¹ | Jan–Aug 2026 | YoY² |
|---|---|---|---|---|
| Coface | 256.1 | 22.7% | 190.4 | +15.2% |
| Allianz Trade | 254.1 | 22.5% | 157.3 | +6.0% |
| AIG | 176.2 | 15.6% | 109.3 | +22.5% |
| Atradius | 160.5 | 14.2% | 80.6 | +35.7% |
| Chubb | 128.7 | 11.4% | 90.5 | -5.6% |
| Avla | 88.8 | 7.9% | 72.7 | +61.2% |
| Cesce | 64.6 | 5.7% | 48.3 | +2.5% |
| Total sample | 1,128.9 | 100% | 749.2 | 15.2% |
BRL million. ¹ Share within the sample. ² Jan–Aug 2026 versus Jan–Aug 2025, calculated from rounded values. Insurer rows may not sum exactly to published totals because of rounding. Source: study, p. 3.
Claims and timing concentration
Over the trailing 12 months, the sample recorded approximately BRL 1,734 million in incurred claims and BRL 1,049 million in earned premiums. The gross loss ratio was 165%. Direct premiums measure production; earned premiums are the denominator for the loss ratio.
AIG accounts for BRL 715.0 million in claims, approximately 41% of the sample’s trailing total. Its 425% gross loss ratio relates claims to earned premiums during that period. It should not be used as a measure of solvency or claims-paying ability.
In August 2026, four insurers recorded BRL 601.1 million in claims, approximately 44% of sample claims for January–August. Incurred claims include reserve additions, revisions and reversals; they do not necessarily equal claims paid during the month. The figures do not establish a common borrower or event.
Claims exceeded earned premiums in 2025 and the trailing 12 months
BRL million · seven insurers · gross loss ratio = incurred claims ÷ earned premiums
Underlying data
| Period | Earned | Claims | Ratio |
|---|---|---|---|
| 2023 | 814 | 764 | 94% |
| 2024 | 821 | 338 | 41% |
| 2025 | 974 | 1213 | 125% |
| 12M Aug/26 | 1049 | 1734 | 165% |
Incurred claims: AIG accounts for approximately 41% of the sample
BRL million · trailing 12 months ended August 2026
Swipe to view the full chart.
August 2026: BRL 601.1 million across four insurers
Incurred claims · isolated month · BRL million
Swipe to view the full chart.
Reinsurance and the local-entity view
The comparison below covers the cumulative January 2023–August 2026 period. The gross measure is incurred claims divided by earned premiums. The estimated net measure adjusts the numerator and denominator for reinsurance income and expense reported in the study.
At the aggregate level, the adjustment reduces the ratio from 112% to 29%. The gap is greater at AIG, at 208% versus 1%, and Atradius, at 139% versus 5%. This shows the accounting effect of reinsurance on the estimated local-entity metric without establishing the group’s final economic result.
The study’s summary also reports a 165% gross ratio and a 36% estimated net ratio for the trailing 12 months. Those figures cover a different window and are not directly compared with the cumulative 112% and 29%. The query does not identify reinsurers: it cannot confirm generalized intragroup cessions, reinsurer credit quality or actual recovery of balances.
Reinsurance: gross versus estimated net loss ratios
Cumulative Jan/2023–Aug/2026 · same period for both measures
Swipe to view the full chart.
Branch differences and study coverage
Cumulatively from January 2023 through August 2026, the domestic credit gross loss ratio was 122%, versus 32% for export credit. Estimated net ratios were 30% and 22%. The difference does not establish net profitability because commissions and other expenses are outside this analysis.
The sample covers only part of SES branch 0748. Other participants and the product mix need to be considered when assessing the entire market. For branch 0749, the seven-insurer totals match the SES totals presented in the study.
By branch: domestic credit shows greater claims pressure
Cumulative Jan/2023–Aug/2026 · seven insurers
Swipe to view the full chart.
How much of each branch does the sample cover?
Share of each branch’s direct premiums · trailing 12 months ended August 2026
Implications for structuring and placement
Businesses should review buyer concentration, limits, payment terms, overdue balances and reporting obligations before renewal. For banks, an assessment should connect borrower, tenor, financing agreement, exclusions and coverage triggers in a non-payment insurance structure.
For a broker, the data informs risk preparation and questions to insurance markets. Historical figures do not establish future price increases, limit reductions or capacity constraints. Each transaction requires current underwriting information and coverage terms.
Sources and methodology
Based on the study supplied for this analysis, using the SES/SUSEP “Insurance: Premiums and Claims” query, branches 0748 and 0749, from January 2023 through August 2026. Sample: Allianz Trade/Euler Hermes, Coface, AIG, Atradius/Crédito y Caución, Chubb, Avla and Cesce. Atradius and Crédito y Caución are treated as one entity. Figures are rounded. The trailing 12-month period runs from September 2025 through August 2026 and overlaps calendar 2025 by four months. Data is subject to SUSEP reloads and revisions.
Raw SES data was not independently re-extracted for this analysis. Reinsurance and branch loss ratios use cumulative data; participation and claims rankings use trailing 12 months.
Eleven acts as an insurance broker. Coverage is subject to insurers’ assessment and acceptance. Eleven does not provide credit or financing.